Children 2-6 years:
Entex®, Rescon GG, Sil-Tex: 2.5 mL every 4-6 hours; maximum 10 mL/24 hours
Sina-12X suspension: 2.5-5 mL every 12 hours
Children 6-12 years:
Aldex™, Crantex LA, Liquibid-D, PhenaVent™ D, Sina-12X tablet: One-half tablet every 12 hours (maximum: 1 tablet/24 hours)
Deconsol® II: One capsule daily
Entex®, Rescon GG: 5 mL every 4-6 hours (maximum: 20 mL/24 hours)
Guaifed-PD®, PhenaVent™ Ped: One capsule every 12 hours
Liquibid-PD, SINUvent® PE: One tablet every 12 hours (maximum: 2 tablets/24 hours)
Prolex™D: One-half to 1 tablet every 12 hours
Sina-12X suspension: Refer to Adults dosing.
Children
12 years:
Aldex™, Crantex LA, Deconsol® II, Entex®, Entex® LA, Guaifed®, Guaifed-PD®, Liquibid-D, Liquibid-PD, PhenaVent™, PhenaVent™ D, PhenaVent™ Ped, Prolex™ D, Rescon GG, Sil-Tex, Sina-12X, SINUvent® PE: Refer to Adults dosing
Crantex ER, Entex® ER: One capsule every 12 hours
Adults:
Aldex™, Crantex LA, Liquibid-D, PhenaVent™ D: One tablet every 12 hours
Crantex ER, Entex® ER, Guaifed-PD®, PhenaVent™ Ped: 1-2 capsules every 12 hours
Deconsol® II: 1-2 capsules every 12 hours (maximum: 3 capsules/24 hours)
Endal®, Prolex™ D: 1-2 tablets every 12 hours
Entex®, Sil-Tex: 5-10 mL every 4-6 hours (maximum: 40 mL/24 hours)
Entex® LA, Guaifed®, PhenaVent™: One capsule every 12 hours (maximum: 2 capsules/24 hours)
Liquibid-PD, Sina-12X tablet: 1-2 tablets every 12 hours (maximum: 4 tablets/24 hours)
Rescon GG: 10 mL every 4-6 hours (maximum: 40 mL/24 hours)
Sina-12X suspension: 5-10 mL every 12 hours
SINUvent® PE: Two tablets every 12 hours
Guaifenesin: No significant effects or complications reported
Phenylephrine: Up to 10% of patients could experience tachycardia, palpitations, and xerostomia (normal salivary flow resumes upon discontinuation); use vasoconstrictor with caution
Capsule, variable release:
Crantex ER, Entex® ER: Guaifenesin 300 mg [immediate release] and phenylephrine hydrochloride 10 mg [extended release]
Deconsal® II: Guaifenesin 375 mg [immediate release] and phenylephrine hydrochloride 20 mg [extended release] [contains tartrazine]
Entex® LA: Guaifenesin 400 mg [immediate release] and phenylephrine hydrochloride 30 mg [extended release]
Guaifed®, PhenaVent™: Guaifenesin 400 mg [immediate release] and phenylephrine hydrochloride 15 mg [extended release]
Guaifed-PD®, PhenaVent™ Ped: Guaifenesin 200 mg [immediate release] and phenylephrine hydrochloride 7.5 mg [extended release]
Liquid: Guaifenesin 100 mg and phenylephrine hydrochloride 7.5 mg per 5 mL (480 mL)
Entex®, Sil-Tex: Guaifenesin 100 mg and phenylephrine hydrochloride 7.5 mg per 5 mL (480 mL) [alcohol free, dye-free, sugar free; punch flavor]
Rescon GG: Guaifenesin 100 mg and phenylephrine hydrochloride 5 mg per 5 mL (120 mL, 480 mL) [cherry orange-pineapple flavor]
Suspension (Sina-12X): Guaifenesin 100 mg and phenylephrine tannate 5 mg per 5 mL (120 mL) [contains benzoic acid; grape flavor]
Tablet:
Amidal: Guaifenesin 300 mg and phenylephrine hydrochloride 20 mg
Sina-12X: Guaifenesin 200 mg and phenylephrine tannate 25 mg
Tablet, extended release: Guaifenesin 600 mg and phenylephrine hydrochloride 20 mg; Guaifenesin 600 mg and phenylephrine hydrochloride 40 mg; Guaifenesin 1200 mg and phenylephrine hydrochloride 40 mg
Aldex™: Guaifenesin 650 mg and phenylephrine hydrochloride 25 mg
Ami-Tex LA: Guaifenesin 600 mg and phenylephrine hydrochloride 30 mg
Liquibid-D: Guaifenesin 600 mg and phenylephrine hydrochloride 40 mg
Liquibid-PD: Guaifenesin 275 mg and phenylephrine hydrochloride 25 mg
PhenaVent™ D: Guaifenesin 1200 mg and phenylephrine hydrochloride 40 mg
SINUvent® PE: Guaifenesin 600 mg and phenylephrine hydrochloride 15 mg
Tablet, sustained release: Guaifenesin 600 mg and phenylephrine hydrochloride 30 mg
Crantex-LA: Guaifenesin 600 mg and phenylephrine hydrochloride 30 mg [dye-free]
Prolex™D: Guaifenesin 600 mg and phenylephrine hydrochloride 20 mg [dye-free]
Tablet, timed release (Endal®): Guaifenesin 300 mg and phenylephrine hydrochloride 20 mg
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |